Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
vaccines
Fierce Pharma
Pfizer CEO Albert Bourla levels criticism of CBER's Vinay Prasad
Pfizer CEO Albert Bourla, Ph.D., has delivered sharp criticism of Vinay Prasad, M.D., and his performance as the chief regulator of U.S. vaccines.
Kevin Dunleavy
Mar 3, 2026 4:58pm
Moderna R&D spend shrunk 31% in 2025 amid major pipeline reorg
Feb 13, 2026 10:10am
Jay Bhattacharya faces Senate grilling on NIH disruptions
Feb 3, 2026 5:20pm
Fierce Pharma
Pfizer CEO blasts RFK Jr. over 'anti-science' vaccine stance: WSJ
Jan 21, 2026 11:01am
Pfizer pens $530M deal to use Novavax adjuvant on 2 programs
Jan 20, 2026 10:40am
ARPA-H director eyes future beyond vaccines
Jan 20, 2026 5:00am
